Holen Sie sich die Stockscreener-App
0.6966
1.35%
0.0093
Schlusskurs vom Vortag:
$0.6873
Offen:
$0.6895
24-Stunden-Volumen:
438.13K
Relative Volume:
0.27
Marktkapitalisierung:
$110.88M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-108.00M
KGV:
-0.4641
EPS:
-1.501
Netto-Cashflow:
$-87.84M
1W Leistung:
+5.71%
1M Leistung:
+1.69%
6M Leistung:
+39.60%
1J Leistung:
-22.58%
1-Tages-Spanne:
$0.682
$0.6999
1-Wochen-Bereich:
$0.68
$0.7699
52-Wochen-Spanne:
$0.3772
$2.445
Fractyl Health Inc Stock (GUTS) Company Profile
Firmenname
Fractyl Health Inc
Sektor
Branche
Telefon
781-902-8800
Adresse
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
0.6966 | 109.05M | 3,000 | -108.00M | -87.84M | -1.501 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-08-28 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-02-28 | Eingeleitet | Evercore ISI | Outperform |
| 2024-02-27 | Eingeleitet | BofA Securities | Buy |
| 2024-02-27 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Fractyl Health Inc Aktie (GUTS) Neueste Nachrichten
Stockholder Alert: Robbins LLP Informs Investors of the Fractyl Health, Inc. Class Action - WBOC TV
Fractyl Health to Host Virtual Commercial Strategy Day on Tuesday, September 1, 2026: The Potential Path to Commercializing Revita®, a Procedural Therapy for Post-GLP-1 Weight Maintenance - The Manila Times
Fractyl Health to Host Virtual Commercial Strategy Day on - GlobeNewswire
Fractyl Health, Inc. Common Stock (NASDAQ: GUTS) Share Price, GUTS Stock News, GUTS Share Price & Updates - Kalkine
GUTS Q2 2026 Earnings: Narrower-than-Expected Loss Signals Cost Discipline Amid Pipeline Progress - vinanet.vn
Fractyl Health (GUTS) Gains 2.72% as Shares Hold Above Key $0.65 SupportConversion Trade - vinanet.vn
Fractyl Health (NASDAQ:GUTS) Downgraded by Wall Street Zen to Sell - MarketBeat
Fractyl Health (GUTS) seeks approval for 1-for-5 to 1-for-15 reverse stock split - Stock Titan
H.C. Wainwright Reiterates Top Pick on Fractyl Health By Investing.com - Investing.com Nigeria
H.C. Wainwright Reiterates Top Pick on Fractyl Health - Investing.com
Fractyl Health Eyes Q4 Revita Data, Launches Rejuva Gene Therapy Trial - MarketBeat
Should I Buy GUTS (Fractyl Health, Inc. Common Stock) | AI Analysis, Technical & News Insights - Kavout | AI
Fractyl Health, Inc.Common Stock (Nasdaq:GUTS) Stock Quote - FinancialContent
Q3 EPS Estimates for Fractyl Health Raised by HC Wainwright - MarketBeat
Fractyl Health (GUTS) Institutional Ownership 2026 $GUTS - MarketBeat
Fractyl Health at Canaccord conference: betting on post-glp-1 care - Investing.com Nigeria
Analysts Set Expectations for Fractyl Health FY2028 Earnings - MarketBeat
Fractyl Health, Inc. (GUTS) Receives a Buy from Bank of America Securities - The Globe and Mail
Fractyl Health, Inc. Common Stock Q2 2026 Earnings Call Summary - Yahoo Finance
Fractyl Says Revita Procedure Kept Off 80% of GLP-1 Weight Loss in One-Year Data - finance.biggo.com
BofA Securities Maintains Fractyl Health(GUTS.US) With Buy Rating, Maintains Target Price $2 - moomoo.com
Earnings call transcript: Fractyl Health beats Q2 2026 EPS estimates By Investing.com - Investing.com UK
Fractyl Health Inc (GUTS) (Q2 2026) Earnings Call Highlights: Pivotal Data on Track and ... - Yahoo Finance Singapore
Fractyl Health Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Fractyl Health beats Q2 2026 EPS estimates - Investing.com
Fractyl Health, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
GUTS: Revita shows durable weight maintenance post-GLP-1, with pivotal data and strong cash runway ahead - TradingView
Fractyl Health (NASDAQ:GUTS) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Fractyl Health Q2 EPS of $(0.16) misses $(0.13) estimate - scanx.trade
FRACTYL HEALTH ($GUTS) Releases Q2 2026 Earnings - Quiver Quantitative
Fractyl Health Reports Second Quarter 2026 Financial Results and Business Updates - GlobeNewswire
Fractyl Health (GUTS) Holds Above $0.70 as Biotech Micro-Cap Stages Cautious ReboundSmart Money Flow Stocks - dars.gov.et
Fractyl Health, Inc. expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Fractyl Health (GUTS.US) will release its earnings report after market close on August 10. - Moomoo
Fractyl Health (GUTS) Projected to Release Quarterly Earnings on Tuesday - MarketBeat
Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026 - The Manila Times
GUTS|Fractyl Health Inc|Price:0.691|Chg%:+0.006 - TradingKey
Fractyl Health to Share Q2 Results Aug. 10 at 4:30 p.m. - Stock Titan
Fractyl Health, Inc. (NASDAQ:GUTS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Fractyl Health, Inc. Revenue Breakdown – NASDAQ:GUTS - TradingView
Fractyl Health Inc (GUTS) Institutional Confidence - TradingKey
Fractyl Health Inc (GUTS) Cash Flow - TradingKey
Fractyl Health Inc (GUTS) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Fractyl Health (GUTS) Edges Higher as Stock Tests Key Resistance Near $0.83Chart Pattern Alerts - vinanet.vn
TradingKey - TradingKey
Fractyl Health Market Sentiment - Benzinga España
Pale Fire Capital SE Buys 2,711,103 Shares of Fractyl Health, Inc. $GUTS - MarketBeat
Enterprise value to revenue forward of Fractyl Health, Inc. – NASDAQ:GUTS - TradingView
Fractyl Health to Participate in Upcoming Investor Events - The Manila Times
Fractyl Health CEO to present at key biotech investor conferences in July and August 2026 - Pluang
Fractyl Health CEO to Join Meetings and Aug. 12 Fireside Chat - Stock Titan
Finanzdaten der Fractyl Health Inc-Aktie (GUTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Fractyl Health Inc-Aktie (GUTS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BRADLEY WILLIAM | Director |
Jun 10 '26 |
Buy |
0.73 |
68,493 |
50,329 |
84,622 |
| Sheffield Ian | Director |
Jun 10 '26 |
Buy |
0.73 |
35,000 |
25,529 |
35,000 |
| Rajagopalan Harith | Chief Executive Officer |
Jun 10 '26 |
Buy |
0.73 |
25,000 |
18,252 |
540,557 |
| Smith Weber Lara | Chief Financial Officer |
Jun 08 '26 |
Buy |
0.69 |
20,000 |
13,708 |
20,000 |
| Rajagopalan Harith | Chief Executive Officer |
Dec 04 '25 |
Buy |
1.92 |
10,416 |
19,999 |
501,745 |
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):